Moderna says its low-dose COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds.
It is the second U.S. vaccine aimed at eventually being offered to children.
Already the Food and Drug Administration is considering kid-sized doses of the Pfizer vaccine for elementary school-aged children - and if regulators give the OK, shots could begin early next month.
As for Moderna, the company said half-dose shots induced strong levels of virus-fighting antibodies in youngsters, with temporary side effects such as fever and fatigue.
(Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.)
Â
